Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 15.67 | -17.42 |
PEG Ratio (TTM) | 0.16 | -5.52 |
P/S Ratio (TTM) | N/A | 38.74 |
P/B Ratio (TTM) | 1.60 | 5.80 |
P/FCF Ratio (TTM) | -1,432.76 | -149.29 |
Price to 5YR AVG Earnings Ratio | N/A | -33.90 |
Price to 5YR AVG FCF Ratio | N/A | -1.08 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 8.57% | 287.17% |
ROE (TTM) | 9.47% | -4,217.47% |
Net Profit Margin (TTM) | N/A | -1,033.79% |
ROIC 5YR AVG | N/A | -16.17% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 4.76% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 11.11% | N/A | N/A |
Cash Flow | -204.86% | N/A | N/A |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.19 | 4.93 |
Quick Ratio (TTM) | 0.19 | 4.91 |
D/E Ratio (TTM) | N/A | 1.29 |
Interest Coverage (TTM) | -187.72 | -11.10 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 45.89 | 20.95 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 889.12% |